101
Views
3
CrossRef citations to date
0
Altmetric
Short Report

Greater Pain Severity is Associated with Inability to Access Addiction Treatment Among a Cohort of People Who Use Drugs

, , ORCID Icon, ORCID Icon, , & show all
Pages 2443-2449 | Published online: 01 Oct 2020

References

  • Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies–tackling the opioid-overdose epidemic. N Engl J Med. 2014;370(22):2063–2066. doi:10.1056/NEJMp1402780
  • Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559–574. doi:10.1146/annurev-publhealth-031914-122957
  • Voon P, Karamouzian M, Kerr T. Chronic pain and opioid misuse: a review of reviews. Subst Abuse Treat Prev Policy. 2017;12(1):36. doi:10.1186/s13011-017-0120-7
  • Worley MJ, Heinzerling KG, Shoptaw S, Ling W. Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain. Exp Clin Psychopharmacol. 2015;23(6):428–435. doi:10.1037/pha0000039
  • Caldeiro RM, Malte CA, Calsyn DA, et al. The association of persistent pain with out-patient addiction treatment outcomes and service utilization. Addiction. 2008;103(12):1996–2005. doi:10.1111/j.1360-0443.2008.02358.x
  • Strathdee SA, Palepu A, Cornelisse PG, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998;280(6):547–549. doi:10.1001/jama.280.6.547
  • Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50(2):133–149. doi:10.1016/0304-3959(92)90154-4
  • Wang L, Panagiotoglou D, Min JE, et al. Inability to access health and social services associated with mental health among people who inject drugs in a Canadian setting. Drug Alcohol Depend. 2016;168:22–29. doi:10.1016/j.drugalcdep.2016.08.631
  • Blumenreich PE, Lewis S. Managing the Violent Patient: A Clinician’s Guide. New York: Brunner/Mazel; 1993.
  • Wright NM, Dixon CA, Tompkins CN. Managing violence in primary care: an evidence-based approach. Br J Gen Pract. 2003;53(492):557–562.
  • Schwartz HI, Pinsker H. Mediating retention or release of the potentially dangerous patient. Hosp Community Psychiatry. 1987;38(1):75–77. doi:10.1176/ps.38.1.75
  • Fitzmaurcie GM, Laird NM, Ware JH. Applied Longitudinal Analysis. New Jersey: John Wiley; 2004.
  • Raudenbush SW, Bryk AS. Hierarchical Linear Models: Applications and Data Analysis Methods. 2nd ed. Thousand Oaks, CA: Sage Publications; 2002.
  • Lang T. Documenting research in scientific articles: guidelines for authors: 3. Reporting multivariate analyses. Chest. 2007;131(2):628–632. doi:10.1378/chest.06-2088
  • Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289(18):2370–2378. doi:10.1001/jama.289.18.2370
  • Jamison RN, Kauffman J, Katz NP. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage. 2000;19(1):53–62. doi:10.1016/S0885-3924(99)00144-X
  • Trafton JA, Oliva EM, Horst DA, Minkel JD, Humphreys K. Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend. 2004;73(1):23–31. doi:10.1016/j.drugalcdep.2003.08.007
  • Passik SD, Hays L, Eisner N, Kirsh KL. Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation. J Pain Palliat Care Pharmacother. 2006;20(2):5–13. doi:10.1080/J354v20n02_03
  • Worley MJ, Heinzerling KG, Shoptaw S, Ling W. Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction. Addiction. 2017;112(7):1202–1209. doi:10.1111/add.13782
  • McPherson C, Collins E, Boyne H, Kirkaldy E, Waseem R. Self-reported chronic pain as a predictor of relapse post residential addiction treatment: a 6-month follow-up pilot study. Int J Ment Health Addict. 2017;15(5):1069–1079. doi:10.1007/s11469-017-9751-1
  • Larson MJ, Paasche-Orlow M, Cheng DM, Lloyd-Travaglini C, Saitz R, Samet JH. Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. Addiction. 2007;102(5):752–760. doi:10.1111/j.1360-0443.2007.01759.x
  • Savage SR, Kirsh KL, Passik SD. Challenges in using opioids to treat pain in persons with substance use disorders. Addict Sci Clin Pract. 2008;4(2):4–25. doi:10.1151/ascp08424
  • Kapuganti A, Turner T, Thomas CJ. Evaluation of buprenorphine/naloxone dose and use of sedating supportive medication on treatment outcomes in veterans with opioid use disorder. Ment Health Clin. 2017;7(6):271–275. doi:10.9740/mhc.2017.11.271
  • Peles E, Schreiber S, Gordon J, Adelson M. Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain. 2005;113(3):340–346. doi:10.1016/j.pain.2004.11.011
  • Voon P, Hayashi K, Milloy MJ, et al. Pain among high-risk patients on methadone maintenance treatment. J Pain. 2015;16(9):887–894. doi:10.1016/j.jpain.2015.06.003
  • Voon P, Greer AM, Amlani A, Newman C, Burmeister C, Buxton JA. Pain as a risk factor for substance use: a qualitative study of people who use drugs in British Columbia, Canada. Harm Reduct J. 2018;15(1):35. doi:10.1186/s12954-018-0241-y
  • Levesque JF, Harris MF, Russell G. Patient-centred access to health care: conceptualising access at the interface of health systems and populations. Int J Equity Health. 2013;12:18. doi:10.1186/1475-9276-12-18
  • Broderick JE, Schwartz JE, Vikingstad G, Pribbernow M, Grossman S, Stone AA. The accuracy of pain and fatigue items across different reporting periods. Pain. 2008;139(1):146–157. doi:10.1016/j.pain.2008.03.024